Related Experiment Videos

Passive smoke exposure is associated with perioperative adverse effects in children

Tulay Hosten Seyidov1, Levent Elemen, Mine Solak

  • 1Department of Anesthesia, Kocaeli University Medical Faculty, Umuttepe/Kocaeli 41380, Turkey. hostentulay@hotmail.com

Journal of Clinical Anesthesia
|February 8, 2011
PubMed

Insights

Children exposed to environmental tobacco smoke (ETS) face higher risks of respiratory issues during general anesthesia recovery. This study found increased laryngospasm and hypersecretion in passively exposed children undergoing surgery.

Area of Science:

  • Anesthesiology
  • Pediatric Medicine
  • Environmental Health

Background:

  • Environmental tobacco smoke (ETS) exposure is a significant health concern in children.
  • Understanding the perioperative risks associated with ETS exposure is crucial for patient safety.

Purpose of the Study:

  • To investigate the incidence of respiratory adverse events in children undergoing general anesthesia who have been passively exposed to cigarette smoke (PSE).

Main Methods:

  • Prospective, double-blinded, observational study conducted in a university hospital setting.
  • Data collected from 385 children undergoing elective surgery between June and November 2008.
  • Passive smoke exposure identified via caregiver reports; respiratory events recorded during and after anesthesia.

Main Results:

  • Overall respiratory adverse events occurred in 15.1% of children (58/385).
  • Children with PSE showed a significantly higher rate of respiratory adverse events (21.4%) compared to non-PSE children (5.3%) (P=0.00).
  • Increased frequency of laryngospasm during anesthesia (P=0.03) and hypersecretions in the recovery room (P=0.00) were observed in the PSE group.

Conclusions:

  • Children exposed to environmental tobacco smoke appear to have an elevated risk of respiratory complications post-general anesthesia.
  • The increased risk is more pronounced in the recovery period than during the anesthesia phase itself.
  • These findings highlight the importance of considering ETS exposure in pediatric perioperative care.
Abstract

Related Concept Videos

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by anesthetizing...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
Chronic Obstructive Pulmonary Disease01:24

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...